Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study Group

Autor: PM Mannucci, DB Brettler, LM Aledort, JM Lusher, CF Abildgaard, RS Schwartz, D Hurst

Publikováno v: Blood. 83(7)

Recent studies suggest that treatment of hemophiliacs with highly purified factor VIII concentrates may preserve immune function. To test this hypothesis, we prospectively studied 51 hemophilic patients (21 human immunodeficiency virus [HIV] seroposi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faad0a117be3da767baa40fed0150fb1
https://pubmed.ncbi.nlm.nih.gov/7908234

The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study

Autor: DB Brettler, PM Mannucci, A Gringeri, JE Rasko, AD Forsberg, MG Rumi, RJ Garsia, KA Rickard, M Colombo

Publikováno v: Blood. 80(2)

To study the transmission rate of hepatitis C virus (HCV) in the female sexual partners of antibody-positive hemophilic males, 106 partners from three hemophilia centers located in Europe, America, and Australia were tested for HCV seropositivity usi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e3083c46a80498f2012f79f3d80b2d1
https://pubmed.ncbi.nlm.nih.gov/1627805

Factor concentrates for treatment of hemophilia: which one to choose? [see comments]

Autor: DB Brettler, PH Levine

Publikováno v: Blood. 73:2067-2073

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ef0a99ab0451d1f3b75d2b576b47c345
https://doi.org/10.1182/blood.v73.8.2067.bloodjournal7382067

Factor VIII:C concentrate purified from plasma using monoclonal antibodies: human studies

Autor: DB Brettler, AD Forsberg, PH Levine, J Petillo, K Lamon, JL Sullivan

Publikováno v: Blood. 73(7)

Conventional clotting factor concentrates have, until recently, been “of intermediate purity,” containing less than 1% of the coagulation factor, and greater than 99% extraneous plasma proteins such as fibrinogen, fibronectin, gamma globulins, an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1be43edb8f62ca764f4c232cd25c7395
https://pubmed.ncbi.nlm.nih.gov/2496775

Laryngeal mucous membrane plasmacytosis with 15 year follow-up: Case report and literature review.

Autor: Makarenko VV; Department of Pathology, UMass Memorial Medical Center, Worcester, MA 01605, USA., Vaezi AE; Department of Otolaryngology, UMass Memorial Medical Center, Worcester, MA 01605, USA., Brettler DB; Department of Hematology-Oncology, UMass Memorial Medical Center, Worcester, MA 01605 USA., Hutchinson L; Department of Pathology, UMass Memorial Medical Center, Worcester, MA 01605, USA., Woda BA; Department of Pathology, UMass Memorial Medical Center, Worcester, MA 01605, USA., Chen BJ; Department of Pathology, UMass Memorial Medical Center, Worcester, MA 01605, USA.

Publikováno v: Leukemia research reports [Leuk Res Rep] 2019 Nov 27; Vol. 13, pp. 100190. Date of Electronic Publication: 2019 Nov 27 (Print Publication: 2020).